UK markets closed
NIKKEI 225
37,552.16 +113.55 (+0.30%) HANG SENG
16,828.93 +317.24 (+1.92%) CRUDE OIL
83.35 +1.45 (+1.77%) GOLD FUTURES
2,339.70 -6.70 (-0.29%) DOW
38,486.77 +246.79 (+0.65%) Bitcoin GBP
53,603.00 +301.75 (+0.57%)
Bone Biologics Corporation (BBLG)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:55PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.41M |
| Enterprise value | -1.62M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.48 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.17 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.58 |
| 52-week change 3 | -97.28% |
| S&P500 52-week change 3 | 23.06% |
| 52-week high 3 | 72.0000 |
| 52-week low 3 | 1.5600 |
| 50-day moving average 3 | 2.4331 |
| 200-day moving average 3 | 4.8669 |
Share statistics
| Avg vol (3-month) 3 | 82.02k |
| Avg vol (10-day) 3 | 37.09k |
| Shares outstanding 5 | 879.18k |
| Implied shares outstanding 6 | 879.18k |
| Float 8 | 480.93k |
| % held by insiders 1 | 8.15% |
| % held by institutions 1 | 1.26% |
| Shares short (28 Mar 2024) 4 | 15.11k |
| Short ratio (28 Mar 2024) 4 | 0.1 |
| Short % of float (28 Mar 2024) 4 | 1.78% |
| Short % of shares outstanding (28 Mar 2024) 4 | 1.72% |
| Shares short (prior month 29 Feb 2024) 4 | 124.81k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 24 Jul 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:8 |
| Last split date 3 | 20 Dec 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -96.34% |
| Return on equity (ttm) | -202.15% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -8.95M |
| Diluted EPS (ttm) | -34.0100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 3.03M |
| Total cash per share (mrq) | 5.66 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 4.50 |
| Book value per share (mrq) | 5.44 |
Cash flow statement
| Operating cash flow (ttm) | -9.56M |
| Levered free cash flow (ttm) | -7.21M |
© 2024 Yahoo. All rights reserved.